BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, Kreft B, Schild H. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology. 2002;222:73-80. [PMID: 11756708 DOI: 10.1148/radiol.2221001599] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Ba-ssalamah A, Happel B, Kettenbach J, Dirisamer A, Wrba F, L�ngle F, Schima W. MRT der Leber: Klinische Bedeutung nichtspezifischer und leberspezifischer MRT-Kontrastmittel. Radiologe 2004;44:1170-84. [DOI: 10.1007/s00117-004-1142-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
2 Kim YK, Kim CS, Lee YH, Kwak HS, Lee JM. Comparison of Superparamagnetic Iron Oxide–Enhanced and Gadobenate Dimeglumine–Enhanced Dynamic MRI for Detection of Small Hepatocellular Carcinomas. American Journal of Roentgenology 2004;182:1217-23. [DOI: 10.2214/ajr.182.5.1821217] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
3 Wang YX. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant Imaging Med Surg 2011;1:35-40. [PMID: 23256052 DOI: 10.3978/j.issn.2223-4292.2011.08.03] [Cited by in F6Publishing: 226] [Reference Citation Analysis]
4 Heiken JP. Distinguishing benign from malignant liver tumours. Cancer Imaging 2007;7 Spec No A:S1-14. [PMID: 17921080 DOI: 10.1102/1470-7330.2007.9084] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
5 Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, Han JK, Choi BI. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology 2015;275:97-109. [PMID: 25559230 DOI: 10.1148/radiol.14140690] [Cited by in Crossref: 237] [Cited by in F6Publishing: 224] [Article Influence: 33.9] [Reference Citation Analysis]
6 Kim SH, Choi D, Kim SH, Lim JH, Lee WJ, Kim MJ, Lim HK, Lee SJ. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2005;184:1069-1076. [PMID: 15788575 DOI: 10.2214/ajr.184.4.01841069] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
7 Yonetomi D, Kadosawa T, Miyoshi K, Nakao Y, Homma E, Hanazono K, Yamada E, Nakamura K, Ijiri A, Minegishi N, Maetani S, Hirayama K, Taniyama H, Nakade T. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions. Vet Radiol Ultrasound 2012;53:371-80. [PMID: 22548505 DOI: 10.1111/j.1740-8261.2011.01919.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
8 Kim TK, Jang HJ, Wilson SR. Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology. Clin Liver Dis 2005;9:253-79. [PMID: 15831272 DOI: 10.1016/j.cld.2004.12.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
9 Chou CT, Wu WP, Chen CB, Su WW, Chen RC, Chen YL. The utility of gadoxetic acid-enhanced MR imaging to characterize atypical cirrhotic nodules detected on dynamic CT images. PLoS One 2014;9:e107869. [PMID: 25310817 DOI: 10.1371/journal.pone.0107869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Kim SH, Choi BI, Lee JY, Kim SJ, So YH, Eun HW, Lee JM, Han JK. Diagnostic accuracy of multi-/single-detector row CT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the milan criteria before liver transplantation. Intervirology. 2008;51 Suppl 1:52-60. [PMID: 18544949 DOI: 10.1159/000122598] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
11 Goshima S, Kanematsu M, Matsuo M, Kondo H, Kato H, Yokoyama R, Hoshi H, Moriyama N. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2004;20:250-255. [PMID: 15269950 DOI: 10.1002/jmri.20100] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
12 He X, Wu J, Holtorf AP, Rinde H, Xie S, Shen W, Hou J, Li X, Li Z, Lai J, Wang Y, Zhang L, Wang J, Li X, Ma K, Ye F, Ouyang H, Zhao H. Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China. PLoS One 2018;13:e0191095. [PMID: 29324837 DOI: 10.1371/journal.pone.0191095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
13 Maurea S, Mainenti PP, Tambasco A, Imbriaco M, Mollica C, Laccetti E, Camera L, Liuzzi R, Salvatore M. Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg. 2014;4:181-189. [PMID: 24914419 DOI: 10.3978/j.issn.2223-4292.2014.01.02] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
14 Chanyaputhipong J, Low SC, Chow PK. Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. Int J Hepatol. 2011;2011:489342. [PMID: 21994860 DOI: 10.4061/2011/489342] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
15 Lee JY, Kim SH, Jeon YH, Lee J, Kim MJ, Choi D, Lee WJ. Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Preoperative Detection of Hepatocellular Carcinoma: Initial Experience. Journal of Computer Assisted Tomography 2010;34:127-34. [DOI: 10.1097/rct.0b013e3181b1587a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
16 Kim YK, Kwak HS, Han YM, Kim CS. Usefulness of Combining Sequentially Acquired Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Resovist-Enhanced Magnetic Resonance Imaging for the Detection of Hepatocellular Carcinoma: Comparison With Computed Tomography Hepatic Arteriography and Computed Tomography Arterioportography Using 16-Slice Multidetector Computed Tomography. Journal of Computer Assisted Tomography 2007;31:702-11. [DOI: 10.1097/rct.0b013e31802d0b6b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
17 Simon G, Link TM, Wörtler K, Doebereiner F, Schulte-Frohlinde E, Daldrup-Link H, Settles M, Rummeny EJ. Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging. Eur Radiol 2005;15:895-903. [PMID: 15800773 DOI: 10.1007/s00330-005-2669-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
18 Jang H, Yu H, Kim TK. Imaging of Focal Liver Lesions. Seminars in Roentgenology 2009;44:266-82. [DOI: 10.1053/j.ro.2009.05.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
19 Takayasu K, Muramatsu Y, Mizuguchi Y, Moriyama N, Okusaka T. Multiple non-tumorous arterioportal shunts due to chronic liver disease mimicking hepatocellular carcinoma: outcomes and the associated elevation of alpha-fetoprotein. J Gastroenterol Hepatol. 2006;21:288-294. [PMID: 16460488 DOI: 10.1111/j.1440-1746.2006.04170.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
20 Lencioni R, Cioni D, Crocetti L, Pina CD, Bartolozzi C. Magnetic resonance imaging of liver tumors. Journal of Hepatology 2004;40:162-71. [DOI: 10.1016/s0168-8278(03)00455-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
21 Caraiani CN, Dan M, Fenesan DI, Badea R. Description of focal liver lesions with Gd-EOB-DTPA enhanced MRI. Clujul Med 2015;88:438-48. [PMID: 26733231 DOI: 10.15386/cjmed-414] [Reference Citation Analysis]
22 Tanimoto A, Kuribayashi S. Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma. Eur J Radiol 2006;58:200-16. [PMID: 16414230 DOI: 10.1016/j.ejrad.2005.11.040] [Cited by in Crossref: 100] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
23 Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T. Potential for Differential Diagnosis with Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging in Experimental Hepatic Tumors. Investigative Radiology 2004;39:80-8. [DOI: 10.1097/01.rli.0000105331.11373.c0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
24 Onishi H, Murakami T, Nakamura H. Diagnosis of Hepatocellular Carcinoma: Multidetector-Row Computed Tomography and Magnetic Resonance Imaging. In: Hayat MA, editor. Liver Cancer. Dordrecht: Springer Netherlands; 2009. pp. 221-35. [DOI: 10.1007/978-1-4020-9804-8_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
26 Young AL, Malik HZ, Abu-Hilal M, Guthrie JA, Wyatt J, Prasad KR, Toogood GJ, Lodge JP. Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg. 2007;205:453-462. [PMID: 17765162 DOI: 10.1016/j.jamcollsurg.2007.04.033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
27 Lencioni R, Crocetti L, Della Pina MC, Cioni D. Guidelines for imaging focal lesions in liver cirrhosis. Expert Review of Gastroenterology & Hepatology 2014;2:697-703. [DOI: 10.1586/17474124.2.5.697] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
28 Zhou Z, Huang D, Bao J, Chen Q, Liu G, Chen Z, Chen X, Gao J. A synergistically enhanced T(1) -T(2) dual-modal contrast agent. Adv Mater 2012;24:6223-8. [PMID: 22972529 DOI: 10.1002/adma.201203169] [Cited by in Crossref: 205] [Cited by in F6Publishing: 188] [Article Influence: 20.5] [Reference Citation Analysis]
29 Kato H, Kanematsu M, Kondo H, Goshima S, Matsuo M, Hoshi H, Moriyama N. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity. J Magn Reson Imaging. 2004;19:76-81. [PMID: 14696223 DOI: 10.1002/jmri.10425] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
30 Layer G, Delorme S. [Radiological diagnosis of hepatic tumors. Part II: Identification and differential diagnosis]. Radiologe 2007;47:919-31; quiz 932-3. [PMID: 17898982 DOI: 10.1007/s00117-007-1564-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Golfieri R, Marini E, Bazzocchi A, Fusco F, Trevisani F, Sama C, Mazzella G, Cavuto S, Piscaglia F, Bolondi L. Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med. 2009;114:1239-1266. [PMID: 19697104 DOI: 10.1007/s11547-009-0439-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
32 Numminen K, Halavaara J, Tervahartiala P, Isoniemi H, Kivisaari L, Palomäki M, Höckerstedt K. Liver tumour MRI: what do we need for lesion characterization? Scandinavian Journal of Gastroenterology 2009;39:67-73. [DOI: 10.1080/00365520310007765] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
33 Ariff B, Lloyd CR, Khan S, Shariff M, Thillainayagam AV, Bansi DS, Khan SA, Taylor-Robinson SD, Lim AK. Imaging of liver cancer. World J Gastroenterol 2009; 15(11): 1289-1300 [PMID: 19294758 DOI: 10.3748/wjg.15.1289] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
34 Hori M, Murakami T, Kim T, Tsuda K, Takahashi S, Okada A, Takamura M, Nakamura H. Detection of Hypervascular Hepatocellular Carcinoma: Comparison of SPIO-enhanced MRI With Dynamic Helical CT: . Journal of Computer Assisted Tomography 2002;26:701-10. [DOI: 10.1097/00004728-200209000-00007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
35 Grazioli L, Morana G, Kirchin MA, Caccia P, Romanini L, Bondioni MP, Procacci C, Chiesa A. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): An intra-individual comparison. J Magn Reson Imaging 2003;17:593-602. [DOI: 10.1002/jmri.10289] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
36 Ba-Ssalamah A, Fakhrai N, Matzek WK, Herneth AM, Stadler A, Bastati N, Herold CJ, Schima W. Magnetic resonance imaging of liver malignancies. Top Magn Reson Imaging 2007;18:445-55. [PMID: 18303402 DOI: 10.1097/rmr.0b013e3181614374] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
37 Ayyappan AP, Jhaveri KS. CT and MRI of hepatocellular carcinoma: an update. Expert Rev Anticancer Ther. 2010;10:507-519. [PMID: 20397916 DOI: 10.1586/era.10.24] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
38 Lee DH, Kim SH, Lee JM, Park HS, Lee JY, Yi NJ, Suh KS, Jang JJ, Han JK, Choi BI. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings. Invest Radiol 2009;44:311-21. [PMID: 19462486 DOI: 10.1097/rli.0b013e31819c9f44] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Yoo HJ, Lee JM, Lee MW, Kim SJ, Lee JY, Han JK, Choi BI. Hepatocellular Carcinoma in Cirrhotic Liver: Double-Contrast-Enhanced, High-Resolution 3.0T-MR Imaging With Pathologic Correlation: . Investigative Radiology 2008;43:538-46. [DOI: 10.1097/rli.0b013e3181768d96] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
40 Tanimoto A. Use of SPIOs for Clinical Liver Imaging. In: Bulte JW, Modo MM, editors. Nanoparticles in Biomedical Imaging. New York: Springer; 2008. pp. 41-61. [DOI: 10.1007/978-0-387-72027-2_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Hekimoglu K, Ustundag Y, Dusak A, Kalaycioglu B, Besir H, Engin H, Erdem O. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging. Eur J Radiol 2011;77:468-72. [PMID: 19781882 DOI: 10.1016/j.ejrad.2009.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
42 Steingruber IE, Mallouhi A, Czermak BV, Waldenberger P, Gassner E, Offner F, Chemelli A, Koenigsrainer A, Vogel W, Jaschke WR. Pretransplantation Evaluation of the Cirrhotic Liver with Explantation Correlation: Accuracy of CT Arterioportography and Digital Subtraction Hepatic Angiography in Revealing Hepatocellular Carcinoma. American Journal of Roentgenology 2003;181:99-108. [DOI: 10.2214/ajr.181.1.1810099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
43 Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology. 2005;237:520-528. [PMID: 16192317 DOI: 10.1148/radiol.2372041183] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
44 Limanond P, Raman SS, Sayre J, Lu DS. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners. J Magn Reson Imaging 2004;20:640-7. [DOI: 10.1002/jmri.20165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
45 Winter PM, Pearce J, Chu Z, McPherson CM, Takigiku R, Lee JH, Qi X. Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine. J Magn Reson Imaging 2015;41:1079-87. [PMID: 24797437 DOI: 10.1002/jmri.24654] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
46 Macarini L, Milillo P, Cascavilla A, Scalzo G, Stoppino L, Vinci R, Moretti G, Ettorre G. MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers. Radiol med 2009;114:1267-82. [DOI: 10.1007/s11547-009-0464-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
47 Ba-ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 2009;19:342-57. [DOI: 10.1007/s00330-008-1172-x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 9.0] [Reference Citation Analysis]
48 Reis MA, Baroni RH. Liver-specific magnetic resonance contrast medium in the evaluation of chronic liver disease. Einstein (Sao Paulo) 2015;13:326-9. [PMID: 26154554 DOI: 10.1590/S1679-45082015RW3159] [Reference Citation Analysis]
49 Coenegrachts K. Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions. World J Radiol 2009; 1(1): 72-85 [PMID: 21160723 DOI: 10.4329/wjr.v1.i1.72] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
50 Yamagata M, Abe M, Handa H, Kawaguchi H. Magnetite/Polymer Composite Particles Prepared by Molecular Assembling Followed by In-Situ Magnetite Formation. Macromol Symp 2006;245-246:363-70. [DOI: 10.1002/masy.200651350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
51 Park Y, Choi D, Kim SH, Kim SH, Kim MJ, Lee J, Lim JH, Lee WJ, Lim HK. Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging. European Journal of Radiology 2006;59:424-31. [DOI: 10.1016/j.ejrad.2006.06.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
52 Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol. 2010;45:133-141. [PMID: 20098330 DOI: 10.1097/rli.0b013e3181caea5b] [Cited by in Crossref: 164] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
53 Chen R, Lii J, Chou C, Chang T, Chen W, Li C, Tu H. T2-weighted and T1-weighted Dynamic Superparamagnetic Iron Oxide (Ferucarbotran) Enhanced MRI of Hepatocellular Carcinoma and Hyperplastic Nodules. Journal of the Formosan Medical Association 2008;107:798-805. [DOI: 10.1016/s0929-6646(08)60193-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
54 Yu JS, Chung JJ, Kim JH, Kim KW. Small hypervascular hepatocellular carcinomas: value of "washout" on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging. Eur Radiol 2009;19:2614-22. [PMID: 19513719 DOI: 10.1007/s00330-009-1465-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
55 Heilmaier C, Lutz AM, Bolog N, Weishaupt D, Seifert B, Willmann JK. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. Radiology 2009;253:724-33. [PMID: 19789232 DOI: 10.1148/radiol.2533090161] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
56 Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17:2519-30. [DOI: 10.1007/s00330-007-0602-5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
57 Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, Choi BI. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. AJR Am J Roentgenol. 2008;191:529-536. [PMID: 18647927 DOI: 10.2214/ajr.07.2565] [Cited by in Crossref: 62] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
58 Low RN. Abdominal MRI advances in the detection of liver tumours and characterisation. Lancet Oncol. 2007;8:525-535. [PMID: 17540304 DOI: 10.1016/S1470-2045(07)70170-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
59 Kim YK, Kim CS, Han YM. Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran. Br J Radiol. 2009;82:468-484. [PMID: 19124563 DOI: 10.1259/bjr/76535286] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
60 Hussain SM, Semelka RC. Hepatic imaging: comparison of modalities. Radiol Clin North Am. 2005;43:929-947, ix. [PMID: 16098348 DOI: 10.1016/j.rcl.2005.05.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
61 Kwak HS, Lee JM, Kim YK, Lee YH, Kim CS. Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging. Eur Radiol 2005;15:140-7. [PMID: 15449000 DOI: 10.1007/s00330-004-2508-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
62 Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB. MR contrast agents for liver imaging: what, when, how. Radiographics. 2006;26:1621-1636. [PMID: 17102040 DOI: 10.1148/rg.266065014] [Cited by in Crossref: 103] [Cited by in F6Publishing: 83] [Article Influence: 6.4] [Reference Citation Analysis]
63 Kim SH, Lee WJ, Lim HK, Park CK. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings. Korean J Radiol 2009;10:112-20. [PMID: 19270856 DOI: 10.3348/kjr.2009.10.2.112] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
64 Morana G, Grazioli L, Testoni M, Caccia P, Procacci C. Contrast Agents for Hepatic Magnetic Resonance Imaging: . Topics in Magnetic Resonance Imaging 2002;13:117-50. [DOI: 10.1097/00002142-200206000-00002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
65 Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology. 2003;228:719-726. [PMID: 12881583 DOI: 10.1148/radiol.2283020735] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]